Mr Paul Riti, RPH | |
4000 Chemical Rd, Suite 100, Plymouth Meeting, PA 19462-1708 | |
(800) 548-9903 | |
Not Available |
Full Name | Mr Paul Riti |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 4000 Chemical Rd, Plymouth Meeting, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053760223 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | RP040812L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Paul Riti, RPH 10960 Knights Rd, Philadelphia, PA 19154-4210 Ph: (215) 612-5505 | Mr Paul Riti, RPH 4000 Chemical Rd, Suite 100, Plymouth Meeting, PA 19462-1708 Ph: (800) 548-9903 |
News Archive
In a study to be presented on February 16 between 8 a.m., and 10 a.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting -, in San Francisco, researchers will report findings that suggest around-the-clock labor and delivery coverage decreased the odds of cesarean delivery.
Mediware Information Systems, Inc. announced today that it has finalized the acquisitions of Healthcare Automation Inc. (HAI) and Advantage Reimbursement Inc. (ARI), which provides software and outsourcing solutions for home health providers.
There is a high probability of obstructive sleep apnea (OSA) in non-obese, middle-aged patients, according to a research abstract that will be presented on Tuesday, June 9, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies.
NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced that it is initiating the first in a series of studies to evaluate the clinical utility of the NanoString Breast Cancer Intrinsic Subtyping Assay.
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company at the forefront of the development of a Universal Influenza Vaccine, announced the success of the Phase I/II clinical trial of the Company's Multimeric-001 Universal Flu Vaccine, in trials conducted at the Sourasky Medical Center in Tel Aviv, Israel.
› Verified 4 days ago
Protus Ukeomah, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Ibezim Okehie, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Obinna Nweke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Suite 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Okwuchi Ugbor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 | |
Mr. Adnan M Sawwan, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 Fax: 610-834-7525 | |
Jay Winters, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4000 Chemical Rd, Suite 100, Plymouth Meeting, PA 19462 Phone: 800-548-9903 Fax: 610-941-0742 | |
Azubuike Edmund Ossai, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2250 Hickory Rd, Ste 240, Plymouth Meeting, PA 19462 Phone: 610-834-1122 |